Top

Published in:

01-12-2020 | Stroke | Clinical study

Thromboembolic or bleeding events with DOACs and AEDs

Published in: Reactions Weekly | Issue 1/2020

Excerpt

In patients with atrial fibrillation, concomitant treatment with direct oral anticoagulants (DOACs) and antiepileptic drugs (AEDs) is associated with the "relatively high rate of thromboembolic events" of 5.7% patient-year, according to study results reported in Clinical Drug Investigation, with a major bleeding rate of 1.9% patient-year. …

Giustozzi M, et al. Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation. Clinical Drug Investigation : 7 Dec 2020. Available from: URL: https://doi.org/10.1007/s40261-020-00982-8

Title: Thromboembolic or bleeding events with DOACs and AEDs
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: Stroke
Antiepileptic Drugs
Direct Oral Anticoagulant
Atrial Fibrillation
Direct Oral Anticoagulant
Antiepileptic Drugs
Carbamazepine
Phenobarbital
Phenobarbital
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-87452-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Thromboembolic or bleeding events with DOACs and AEDs

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Multiple drugs

Soya-oil-emulsion

Interferon alpha/insulin

Paclitaxel

Ipilimumab/nivolumab

Pembrolizumab